Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3925271)

Published in Eur J Hum Genet on July 17, 2013

Authors

Rhona MacLeod1, Anna Beach1, Sasha Henriques1, Jasmin Knopp2, Katie Nelson1, Lauren Kerzin-Storrar1

Author Affiliations

1: 1] Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre (MAHSC), Manchester, UK [2] Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, MAHSC, Manchester, UK.
2: 1] Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre (MAHSC), Manchester, UK [2] School of Psychological Sciences, University Of Manchester, Manchester, UK.

Articles cited by this

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol (2012) 2.25

Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet (2000) 2.18

"You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet C Semin Med Genet (2008) 1.87

Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics. Eur J Hum Genet (2009) 1.80

Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology (2005) 1.76

Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet (2006) 1.29

Recommendations for the predictive genetic test in Huntington's disease. Clin Genet (2012) 1.27

Impact of genetic testing for Huntington disease on the family system. Am J Med Genet (2000) 1.26

Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur J Hum Genet (2003) 1.23

Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet (2012) 1.20

Telephone or face-to-face interviews?: a decision made on the basis of a pilot study. Int J Nurs Stud (1998) 1.06

Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test. Health Psychol (2004) 1.04

Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet (2008) 1.01

Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information. Eur J Hum Genet (2009) 0.99

Predictive genetic testing for cardiovascular diseases: impact on carrier children. Am J Med Genet A (2008) 0.96

'Cancer doesn't have an age': genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24. Health (London) (2012) 0.95

Comparison of genetic services with and without genetic registers: access and attitudes to genetic counselling services among relatives of genetic clinic patients. J Med Genet (2002) 0.92

Toward a new understanding of risk perception among young female BRCA1/2 "previvors". Fam Syst Health (2012) 0.90

Being young, female, and BRCA positive. Am J Nurs (2012) 0.89

Genotype in BRCA-associated breast cancers. Breast J (2012) 0.84

Comparison of genetic services with and without genetic registers: knowledge, adjustment, and attitudes about genetic counselling among probands referred to three genetic clinics. J Med Genet (2002) 0.84

The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer (2009) 0.84

Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet (2010) 0.82